❭ Research by medical division ❭ Cancer Medicine ❭ Institute for Cancer Research ❭ Dept. of Cancer Genetics ❭ Genomic alterations in breast cancer [Russnes] ❭ Collaborating projects ❭

Collaborating projects

InPreD

IMPRESS

EMIT

Scroll to top

Home Dept. of Cancer Genetics Genomic alterations in breast cancer [Russnes]

  • Group members
  • Projects
  • Publications
  • Collaborating projects

Recent publications

Asphaug L, Akslen LA, Blix ES, Boge B, Borgen EF, Brekke MB, Falk RS, Geitvik GA, Gilje B, Gravdehaug B, Heie A, Janssen E, Kiserud CE, Kursetgjerde T, Langerød A, Lømo J, Mannsåker B, Mortensen E, Olsson P, Porojnicu AC, Raj SX, Roe OD, Russnes HEG, Skjerven HK, Songe-Møller S et al. (2025)
Cost-effectiveness of Prosigna for Adjuvant Treatment Decisions in Early Breast Cancer: Healthcare Sector and Societal Perspectives
Clin Breast Cancer (in press)
DOI 10.1016/j.clbc.2025.04.011, PubMed 40348620

Wei Q, Foyn H, Landskron J, Wang S, Rye IH, Skånland SS, Russnes HEG, Klaveness J, Ahmad R, Taskén K (2025)
Identification of a group of 9-amino-acridines that selectively downregulate regulatory T cell functions through FoxP3
iScience, 28 (3), 111931
DOI 10.1016/j.isci.2025.111931, PubMed 40034859

Westphalen CB, Boscolo Bielo L, Aftimos P, Beltran H, Benary M, Chakravarty D, Collienne M, Dienstmann R, El Helali A, Gainor J, Horak P, Le Tourneau C, Marchiò C, Massard C, Meric-Bernstam F, Pauli C, Pruneri G, Roitberg F, Russnes HEG, Solit DB, Starling N, Subbiah V, Tamborero D, Tarazona N, Turnbull C et al. (2025)
ESMO Precision Oncology Working Group recommendations on the structure and quality indicators for molecular tumour boards in clinical practice
Ann Oncol (in press)
DOI 10.1016/j.annonc.2025.02.009, PubMed 40194904

More publications

Oslo University Hospital is a part of Southern and Eastern Norway Regional Health Authority.

Webmaster for research pages: Trond Olav Berg

Cookie policy

Accessibility statement (in Norwegian)